Energy Conference: Decarbonization - A Business Perspective REGISTER

Rutgers University Ranks 21st Among Top 100 Worldwide Universities Granted U.S. Utility Patents In 2016  Rutgers University ranks 21st among the Top 100 Worldwide Universities Granted U.S. Utility Patents in 2016, according to a new report published by the National Academy of Inventors (NAI) and Intellectual Property Owners Association (IPO). “Research plays a fundamental role at Rutgers and is a critical part of the university’s mission. Our ability to transfer that research and new technologies to industry helps our state’s economy,” said Christopher J. Molloy, Ph.D., R.Ph., Senior Vice President for Research and Economic Development at Rutgers, The State University of New Jersey.
 

Choose New Jersey Helps Evotec Celebrate Opening of U.S. Headquarters, Facility Expansion in Princeton  Evotec AG, a global drug discovery alliance and development partnership company headquartered in Hamburg, Germany, celebrated the opening of its U.S. headquarters and expanded facility in Princeton, New Jersey. Werner Lanthaler, Chief Executive Officer of Evotec AG and Ryan Brady, the company’s Executive Vice President Business Development and Head of U.S. Operations were joined by Michele Brown, President and CEO of Choose New Jersey, Inc.
 

NJEDA Urges Emerging Tech and Life Sciences Companies to Apply for Funding Brandon Scalea reports in The Star-Ledger that an application administered by the New Jersey Economic Development Authority (EDA) is available for early-stage companies to gain access to capital. The New Jersey Technology Business Tax Certificate Transfer (NOL) Program is targeted to up-and-coming technology and life science companies in the state. The online application is due June 30. Kathleen Coviello, EDA director of technology and life sciences, said all eligible companies should take advantage of this opportunity.
 
Three PhRMA Reports Highlight Increasing Global Competition in Biopharmaceutical R&D, Posing Challenges to Future U.S. Standing As the U.S. looks to maintain its global leadership in biopharmaceutical research and development, three new reports point to an increasingly competitive global environment – one that requires a thorough assessment of our current public policies. That includes the biopharmaceutical industry’s investments in science, technology, engineering and mathematics (STEM)-based initiatives at the state and national levels given the growing efforts of other countries to compete for the high-wage jobs and robust economic contributions of innovative biopharmaceutical companies.
 
Dr. George A. Pruitt to Retire as President of Thomas Edison State University; 35 Years with University Dr. George A. Pruitt will retire as president of Thomas Edison State University at the end of this year, after more than three decades of leading New Jersey’s only institution of higher education dedicated exclusively for adults. “Serving as president of this wonderful university has been the single, greatest privilege of my professional life,” said Pruitt. “I have no words to express my appreciation to the trustees, past and present, as well as my colleagues who have joined in the work of transforming the lives of the students we serve.”
 
State Senator Sarlo, Assemblyman Bramnick and Industry Leaders Support Makerspace at NJIT The New Jersey Institute of Technology (NJIT) on June 2 announce the support of State Senator Paul A. Sarlo (D-Bergen) and Assembly Republican Leader Jon Bramnick (R-Union), as well as numerous industry leaders for an allocation in New Jersey’s Fiscal Year 2018 State Budget to support Makerspace at NJIT. Joining Senator Sarlo and Assemblyman Bramnick in support of a $10 million allocation to this project are the Research and Development Council of New Jersey; ExxonMobil Research and Engineering; Sharp Robotics; Specialty Systems, Inc.; Panasonic Corporation of North America; Stryker Joint Replacement; SMH International; Imperial Machine and Tool Co.; and the U.S. Army Research Development and Engineering Center.
 
Opinion: Former Merck CEO and Princeton University President Emeritus on Trump’s War on Science Threatens U.S. Prosperity Roy Vagelos, retired chairman and CEO of Merck & Co. and chairman of the Board of Regeneron Pharmaceuticals, and Shirley Tilghman, President Emeritus of Princeton University and a professor of Molecular Biology and Public Affairs, published the following opinion piece in The Star-Ledger on June 6: In the past 40 years, the U.S. has been the world leader in converting fundamental scientific discoveries into innovative new treatments for life-threatening disease. New drugs, vaccines, and medical devices have improved human health and increased our lifespan.
 
Stockton University to Launch New Master’s in Data Science and Strategic Analytics This Fall Harnessing “Big Data” – the vast sea of digital information generated daily by business, science, entertainment and education – is a challenge but also an opportunity, and Stockton University is launching a new degree program this fall to prepare graduates for this fast-growing field. The first classes for the Master of Science in Data Science and Strategic Analytics within the School of Natural Sciences and Mathematics (NAMS) will be held in September with approximately 12 students to start and enrollment is expected to grow to a maximum of 25 in future years.

 

Upcoming Events

 

2017 Women’s Healthcare Innovation and Leadership Showcase (WHILS)

When: Wed, June 14, 11:30am – 7:30pm
Where: Rutgers University – Robert Wood Johnson Medical School, Kessler Teaching Building, 683 Hoes Lane West, Piscataway

 

NJEN’s Annual “Gathering of Angels”
When: Wed, June 14, 11:30am – 3:00pm
Where: Kean University, STEM Building,1075 Morris Avenue, Union

 

Choose New Jersey and HINJ to Host Reception at BIO International 2017
When: Mon, June 19, 5pm – 7pm
Where: Hyatt at the Grand Hyatt San Diego

 

2017 ManufactureNJ Industry Summit — Save the Date!
When: Wednesday, Aug 23, 2017
Where: NJIT, Newark